{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:13:01Z","timestamp":1790421181351,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.bcmd.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T12:15:39Z","timestamp":1375877739000},"page":"277-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The impact of trisomy 21 on foetal haematopoiesis"],"prefix":"10.1016","volume":"51","author":[{"given":"Irene","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.07.008_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/00006450-200006000-00002","article-title":"Susceptibility to leukemia and resistance to solid tumors in Down syndrome","volume":"47","author":"Zipursky","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2009.07789.x","article-title":"Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multistep model of leukaemogenesis","volume":"147","author":"Roy","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0020","first-page":"608","article-title":"Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group studies 2861 and 2891","volume":"91","author":"Lange","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0025","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-10-3446","article-title":"Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study","volume":"106","author":"Whitlock","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0030","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0035","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","article-title":"Risk factors for early death in neonates with Down syndrome and transient leukaemia","volume":"142","author":"Muramatsu","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0045","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group study A2971","volume":"118","author":"Gamis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0050","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","article-title":"Natural history of GATA1 mutations in Down syndrome","volume":"103","author":"Ahmed","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0060","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2002-11-3599","article-title":"Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21","volume":"102","author":"Rainis","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0065","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","article-title":"GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome","volume":"10","author":"Hitzler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0070","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2003-02-0390","article-title":"Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0075","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(03)13266-7","article-title":"Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder","volume":"361","author":"Groet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng1825","article-title":"An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis","volume":"38","author":"Hollanda","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0085","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pgen.0020050","article-title":"Understanding the basis for Down syndrome phenotypes","volume":"2","author":"Roper","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0090","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","article-title":"Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations","volume":"112","author":"Tunstall-Pedoe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0095","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2008-05-157859","article-title":"Trisomy 21 enhances human fetal erythro-megakaryocytic development","volume":"112","author":"Chou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0100","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.1211405109","article-title":"Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21","volume":"109","author":"Roy","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0105","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.1215468109","article-title":"Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells","volume":"109","author":"Maclean","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0110","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.1211175109","article-title":"Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells","volume":"109","author":"Chou","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3476(05)81149-7","article-title":"Erythrocyte macrocytosis in infants and children with Down syndrome","volume":"121","author":"Starc","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2007-04-085670","article-title":"Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome","volume":"111","author":"Kirsammer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0125","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2009-06-227629","article-title":"Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome","volume":"115","author":"Alford","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00277-005-1034-4","article-title":"Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS)","volume":"84","author":"Cantu Rajnoldi","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0145","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1073\/pnas.0813248106","article-title":"The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies","volume":"106","author":"Korbel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0150","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2008-06-161422","article-title":"Hematopoietic defects in the Ts1Cje mouse model of Down syndrome","volume":"113","author":"Carmichael","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0160","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1182\/blood-2002-09-2708","article-title":"RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation","volume":"101","author":"Elagib","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0165","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/sj.leu.2404223","article-title":"Physical association of the patient- specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome","volume":"20","author":"Xu","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0170","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1182\/blood-2008-08-174813","article-title":"ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells","volume":"113","author":"Stankiewicz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0175","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1158\/0008-5472.CAN-09-0075","article-title":"ERG is an oncogene","volume":"69","author":"Salek-Ardakani","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0180","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood-2004-07-2826","article-title":"Transgenic expression of BACH1 transcription factor results in megakaryocytic impairment","volume":"105","author":"Toki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0185","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2010-09-306563","article-title":"GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem\/progenitor cells","volume":"117","author":"Yu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0190","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1182\/blood-2009-11-255976","article-title":"RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis","volume":"117","author":"Schnittger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0195","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.0511150103","article-title":"Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling","volume":"103","author":"Bourquin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20091617","article-title":"Reflections on studies of gene expression in aneuploids","volume":"426","author":"Birchler","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0205","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1073\/pnas.0600587103","article-title":"MicroRNA fingerprints during human megakaryocytopoiesis","volume":"103","author":"Garzon","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1101\/gad.1856210","article-title":"miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia","volume":"24","author":"Klusmann","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0215","doi-asserted-by":"crossref","first-page":"e60482","DOI":"10.1371\/journal.pone.0060482","article-title":"Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome","volume":"8","author":"Gribble","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0220","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood-2009-09-242107","article-title":"Trisomy of ERG is required for myeloproliferation in a mouse model of Down syndrome","volume":"115","author":"Ng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0225","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI60455","article-title":"Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome","volume":"122","author":"Malinge","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0230","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2004-04-1563","article-title":"Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome","volume":"104","author":"Taub","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ncponc0876","article-title":"Severe TMD\/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome","volume":"4","author":"Heald","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mce.2008.02.022","article-title":"The role of parathyroid hormone and insulin-like growth factors in hematopoietic niches: physiology and pharmacology","volume":"288","author":"Garrett","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0245","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2003-08-2955","article-title":"Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.07.008_bb0250","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.1003586107","article-title":"Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells","volume":"107","author":"Chou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2013.07.008_bb0255","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1101\/gad.1903410","article-title":"Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis","volume":"24","author":"Klusmann","year":"2010","journal-title":"Genes Dev."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:52Z","timestamp":1761049852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1079979613001599"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.07.008","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of trisomy 21 on foetal haematopoiesis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}